Gancotamab
Gancotamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
| Trade Name | Gancotamab |
| Generic | Gancotamab |
| Gancotamab Other Names | Gancotamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Gancotamab
